Preventing synaptic deficits in Alzheimer’s disease by inhibiting tumor necrosis factor alpha signaling

The characterization of preclinical stages of Alzheimer’s disease (AD) would provide a therapeutic window for prevention. One of the challenges of developing preventive therapy for AD is to identify early biomarkers for intervention studies. We have recently shown that in the TgCRND8 transgenic AD m...

Full description

Bibliographic Details
Main Authors: Chelsea Cavanagh, Tak Pan Wong
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:IBRO Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2451830117300468

Similar Items